Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer-Reference-Cited by-同舟云学术

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer

Published:2013-09 Issue:3 Volume:81 Page:428-434
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Schmid-Bindert Gerald,Gebbia Vittorio,Mayer Frank,Arriola Edurne,Márquez-Medina Diego,Syrigos Kostas,Biesma Bonne,Leschinger Monika Iris,Frimodt-Moller Bente,Ripoche Veronique,Myrand Scott P.,Nguyen Tuan S.,Hozak Rebecca R.,Zimmermann Annamaria,Visseren-Grul Carla,Schuette Wolfgang

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Peters;Ann Oncol,2012

2. 2011 Focused update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol,2011

3. Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications;Chattopadhyay;Mol Cancer Ther,2007

4. www.ema.europa.eu. Alimta; 2011. http://www.ema.europa.eu/ema/index.jsp?curl=pages/home/Home_Page.jsp&mid.

5. www.lilly.com. Alimta package insert, 5/2012 update. http://pi.lilly.com/us/alimta-pi.pdf.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis;Cancer Treatment Reviews;2019-01

2. Cetuximab for treating non-small cell lung cancer;Expert Opinion on Biological Therapy;2018-03-20

3. Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes;Therapeutic Advances in Medical Oncology;2016-05

4. Glucocorticoid receptors in lung cancer: new perspectives;Journal of Endocrinology;2016-04

5. Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2016-01